Other health innovation funding rounds this week went to companies working on elder care, metabolic health, clinical trials, neurotech, women’s health, mental health, and more.
This week’s reported health innovation funding included:
Waymark, a San Francisco, CA-based Medicaid provider enablement company, raised $42M led by Lux Capital, with participation from CVS Health Ventures, Andreessen Horowitz (a16z), and New Enterprise Associates (NEA). <source>
Greater Good Health, an El Segundo, CA-based elder-focused primary care provider, raised $20M led by Flare Capital Partners, with participation from LRVHealth, Health Velocity Capital, Martin Ventures, and Optum Ventures. <source>
Signos, a Burlingame, CA-based metabolic health platform, raised $20M co-led by Cheyenne Ventures and Google Ventures (GV), with participation from Dexcom Ventures and Samsung Next. <source>
PhaseV, an Israeli startup that develops causal machine learning tech to optimize clinical trial design and analysis, raised $15M led by Viola Ventures and Exor Ventures, with participation from LionBird and angel investors. <source>
CIONIC, a San Francisco, CA-based neurotech company developing FDA-cleared bionic clothing for people with mobility differences, raised $12M led by L Catterton, with participation from THVC and other existing investors. <source>
Allara, a New York, NY-based virtual care platform for women of reproductive age with chronic hormonal conditions, raised $10M led by Google Ventures (GV), with participation from Great Oaks Venture Capital, Humbition, Vanterra, Gaingels, and individual investors. <source>
Pair Team, a San Francisco, CA-based provider of a virtual and community-based primary care solution, raised $9M led by Next Ventures, with participation from PTX Capital, Kapor Capital, Kleiner Perkins, Y Combinator, Create Health Ventures, Augment Ventures, OCA Ventures, CHCF Innovation Fund, and angel investors. <source>
Thoughtful, a New York, NY-based mental health app designed to help combat loneliness, raised $7M from VCP Ventures. <source>
Gero, a Palo Alto, CA-based biotechnology company focused on aging and chronic diseases, raised $6M led by Melnichek Investments, with participation from VitaDAO and Leonid Lozner. <source>
Lillian Care, a Heidelberg, Germany-based health tech company that establishes hybrid practices for general medicine throughout Germany, raised €2.4M ($2.6M) led by Nina Capital, with participation from Aescuvest, Caesar Ventures, OHA BTG, Calmstorm, and individual investors. <source>
Healthcaters, a Berlin, Germany-based developer of a medical self-screening station and an AI-powered health coaching app, raised $1.2M led by Barmenia Next Strategies, with the participation of Venpace, DvH Ventures, and angel investors. <source>
Data is from StartUp Health Insights, the most comprehensive funding database for health innovation. Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.
Call for T1D Innovation
Are you a scientist or innovator focused on T1D innovation who would benefit from education about how to navigate and build a company that will be successful in attracting mission-aligned capital, customers, and collaborators to pursue scientific discoveries in the field of Type 1 diabetes? Learn more and apply for one of the first 25 T1D Fellowships.
Become a Health Moonshot Champion
Health moonshots are fueled by passionate families, foundations, and industry organizations committed to achieving health moonshots. Learn how you can join other champions of the T1D Moonshot or one of our other global health moonshots.
Passionate about breaking down health barriers? If you’re an entrepreneur or investor, contact us to learn how you can join our Health Equity Moonshot.
Investors: Learn how you can become a Health Moonshot Champion and invest in Health Transformers.
Digital health entrepreneur? Don’t make the journey alone. Learn how Health Transformer University fuels your health moonshot.
Follow us on social media for daily updates on Health Transformers: Twitter, LinkedIn, Facebook, and Instagram.